Judge Grants Novartis Summary Judgment on Elidel Claims




PHILADELPHIA - A Pennsylvania federal judge on July 9 granted Novartis Pharmaceuticals Corp. summary judgment on claims that its Elidel (pimecrolimus) Cream caused a child to contract lymphoma. Perry, et al. v. Novartis Pharmaceuticals Corp., et al., No. 05-5350 (E.D. Pa.).

Judge Stewart Dalzell of the U.S. District Court for the Eastern District of Pennsylvania excluded the testimony of the plaintiffs' experts, deeming it unreliable because it fails to consider possible idiopathic causes of the boy's cancer.

The parents of Andreas Perry sued Novartis, claiming that their son's six-month use of Elidel to treat his eczema caused him to develop …






UPCOMING CONFERENCES




HarrisMartin's Webinar Series: Video Game Addiction Product Liability Litigation

March 29, 2024

MORE DETAILS



HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates

May 29, 2024

MORE DETAILS